Preclinical evaluation of diagnosis of actinic keratosis and cutaneous squamous cell carcinoma
Recruiting
- Conditions
- solar keratosis10040900
- Registration Number
- NL-OMON32657
- Lead Sponsor
- niversitair Medisch Centrum Sint Radboud
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Patients with actinic keratoses as well as squamous cell carcinoma
Age above 18 years
Exclusion Criteria
Pregnancy or breast feeding
History with photodermatosis
Systemic or topical treatment interfering with the disease
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The difference in fluorescence intensity between actinic keratoses and squamous<br /><br>cel carcinoma</p><br>
- Secondary Outcome Measures
Name Time Method <p>Thickness of the stratum corneum in the different diseases</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie actinic keratosis progression to cutaneous squamous cell carcinoma?
How does FDAP compare to standard-of-care diagnostics for solar keratosis and cSCC in clinical accuracy?
Which biomarkers are associated with early detection of actinic keratosis using FDAP technology?
What adverse events are reported in invasive diagnostic trials for cutaneous squamous cell carcinoma?
Are there combination diagnostic approaches involving FDAP for non-melanoma skin cancer subtypes?